,index,gene,pagerank_score,source_disease,ensembl_gene_id,druggability_tier,hgnc_names,chr_b37,start_b37,end_b37,strand,description,no_of_gwas_regions,small_mol_druggable,bio_druggable,adme_gene
0,0,FYN,0.1084722904010023,PD,ENSG00000010810,Tier 1,FYN,6,111981535.0,112194655.0,-1.0,"FYN oncogene related to SRC, FGR, YES [Source:HGNC Symbol;Acc:4037]",1.0,1.0,1.0,1.0
0,0,FYN,0.1084722904010023,Schizophrenia,ENSG00000010810,Tier 1,FYN,6,111981535.0,112194655.0,-1.0,"FYN oncogene related to SRC, FGR, YES [Source:HGNC Symbol;Acc:4037]",1.0,1.0,1.0,1.0
1,1,STAT3,0.0395613916131605,MS,ENSG00000168610,Tier 1,STAT3,17,40465342.0,40540586.0,-1.0,signal transducer and activator of transcription 3 (acute-phase response factor) [Source:HGNC Symbol;Acc:11364],6.0,1.0,1.0,1.0
2,2,ITGB5,0.0170216398838733,MigraineDisorder,ENSG00000082781,Tier 1,ITGB5,3,124480795.0,124620265.0,-1.0,"integrin, beta 5 [Source:HGNC Symbol;Acc:6160]",0.0,1.0,1.0,1.0
3,3,RELN,0.0154772933684254,PartialEpilepsy,ENSG00000189056,Tier 3A,RELN,7,103112231.0,103629963.0,-1.0,reelin [Source:HGNC Symbol;Acc:9957],1.0,1.0,1.0,1.0
4,4,SNCA,0.0141574024542975,LBD,ENSG00000145335,Tier 2,SNCA,4,90645250.0,90759466.0,-1.0,"synuclein, alpha (non A4 component of amyloid precursor) [Source:HGNC Symbol;Acc:11138]",13.0,1.0,1.0,1.0
4,4,SNCA,0.0141574024542975,PD,ENSG00000145335,Tier 2,SNCA,4,90645250.0,90759466.0,-1.0,"synuclein, alpha (non A4 component of amyloid precursor) [Source:HGNC Symbol;Acc:11138]",13.0,1.0,1.0,1.0
5,5,CRH,0.0139785074987254,PartialEpilepsy,ENSG00000147571,Tier 3B,CRH,8,67088620.0,67090960.0,-1.0,corticotropin releasing hormone [Source:HGNC Symbol;Acc:2355],0.0,1.0,1.0,1.0
6,6,TLR4,0.013030560340936,NeuroticDisorder,ENSG00000136869,Tier 2,TLR4,9,120466610.0,120479149.0,1.0,toll-like receptor 4 [Source:HGNC Symbol;Acc:11850],0.0,1.0,1.0,1.0
6,6,TLR4,0.013030560340936,UnipolarDepression,ENSG00000136869,Tier 2,TLR4,9,120466610.0,120479149.0,1.0,toll-like receptor 4 [Source:HGNC Symbol;Acc:11850],0.0,1.0,1.0,1.0
7,7,ITGA8,0.0119392980899696,PD,ENSG00000077943,Tier 3A,ITGA8,10,15555948.0,15762124.0,-1.0,"integrin, alpha 8 [Source:HGNC Symbol;Acc:6144]",0.0,1.0,1.0,1.0
8,8,WNT3,0.0108908355748852,PD,ENSG00000108379,Tier 2,WNT3,17,44839872.0,44910520.0,-1.0,"wingless-type MMTV integration site family, member 3 [Source:HGNC Symbol;Acc:12782]",13.0,1.0,1.0,1.0
8,8,WNT3,0.0108908355748852,Schizophrenia,ENSG00000108379,Tier 2,WNT3,17,44839872.0,44910520.0,-1.0,"wingless-type MMTV integration site family, member 3 [Source:HGNC Symbol;Acc:12782]",13.0,1.0,1.0,1.0
9,9,ERBB4,0.0099928719735686,ALS,ENSG00000178568,Tier 1,ERBB4,2,212240446.0,213403565.0,-1.0,v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 [Source:HGNC Symbol;Acc:3432],1.0,1.0,1.0,1.0
9,9,ERBB4,0.0099928719735686,FrontotemporalDementia,ENSG00000178568,Tier 1,ERBB4,2,212240446.0,213403565.0,-1.0,v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 [Source:HGNC Symbol;Acc:3432],1.0,1.0,1.0,1.0
9,9,ERBB4,0.0099928719735686,MajorDepressiveDisorder,ENSG00000178568,Tier 1,ERBB4,2,212240446.0,213403565.0,-1.0,v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 [Source:HGNC Symbol;Acc:3432],1.0,1.0,1.0,1.0
9,9,ERBB4,0.0099928719735686,UnipolarDepression,ENSG00000178568,Tier 1,ERBB4,2,212240446.0,213403565.0,-1.0,v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 [Source:HGNC Symbol;Acc:3432],1.0,1.0,1.0,1.0
10,10,IL7R,0.0098011071176279,MS,ENSG00000168685,Tier 3A,IL7R,5,35852797.0,35879705.0,1.0,interleukin 7 receptor [Source:HGNC Symbol;Acc:6024],4.0,1.0,1.0,1.0
11,11,LEPR,0.0094563731796125,Schizophrenia,ENSG00000116678,Tier 3A,LEPR,1,65886248.0,66107242.0,1.0,leptin receptor [Source:HGNC Symbol;Acc:6554],8.0,1.0,1.0,1.0
12,12,IL12A,0.0094086809081171,MS,ENSG00000168811,Tier 3A,IL12A,3,159706537.0,159713806.0,1.0,"interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) [Source:HGNC Symbol;Acc:5969]",2.0,1.0,1.0,1.0
13,13,APOE,0.0091565301929154,AD,ENSG00000130203,Tier 3A,APOE,19,45409011.0,45412650.0,1.0,apolipoprotein E [Source:HGNC Symbol;Acc:613],84.0,1.0,1.0,1.0
13,13,APOE,0.0091565301929154,LBD,ENSG00000130203,Tier 3A,APOE,19,45409011.0,45412650.0,1.0,apolipoprotein E [Source:HGNC Symbol;Acc:613],84.0,1.0,1.0,1.0
13,13,APOE,0.0091565301929154,PD,ENSG00000130203,Tier 3A,APOE,19,45409011.0,45412650.0,1.0,apolipoprotein E [Source:HGNC Symbol;Acc:613],84.0,1.0,1.0,1.0
14,14,GAL,0.008323343520554,PartialEpilepsy,ENSG00000069482,Tier 3B,GAL,11,68451247.0,68458643.0,1.0,galanin/GMAP prepropeptide [Source:HGNC Symbol;Acc:4114],0.0,1.0,1.0,1.0
15,15,NRXN1,0.0074695985540027,Schizophrenia,ENSG00000179915,Tier 3A,NRXN1,2,50145643.0,51259674.0,-1.0,neurexin 1 [Source:HGNC Symbol;Acc:8008],0.0,1.0,1.0,1.0
15,15,NRXN1,0.0074695985540027,UnipolarDepression,ENSG00000179915,Tier 3A,NRXN1,2,50145643.0,51259674.0,-1.0,neurexin 1 [Source:HGNC Symbol;Acc:8008],0.0,1.0,1.0,1.0
16,16,NOTCH3,0.0069393491260868,MigraineDisorder,ENSG00000074181,Tier 3B,NOTCH3,19,15270444.0,15311792.0,-1.0,notch 3 [Source:HGNC Symbol;Acc:7883],0.0,1.0,1.0,1.0
16,16,NOTCH3,0.0069393491260868,MigraineWithAura,ENSG00000074181,Tier 3B,NOTCH3,19,15270444.0,15311792.0,-1.0,notch 3 [Source:HGNC Symbol;Acc:7883],0.0,1.0,1.0,1.0
17,17,APP,0.0066721972479703,AD,ENSG00000142192,Tier 1,APP,21,27252861.0,27543446.0,-1.0,amyloid beta (A4) precursor protein [Source:HGNC Symbol;Acc:620],0.0,1.0,1.0,1.0
18,18,FSTL5,0.0064604736114369,BipolarDisorder,ENSG00000168843,Tier 3A,FSTL5,4,162305049.0,163085187.0,-1.0,follistatin-like 5 [Source:HGNC Symbol;Acc:21386],0.0,1.0,1.0,1.0
18,18,FSTL5,0.0064604736114369,UnipolarDepression,ENSG00000168843,Tier 3A,FSTL5,4,162305049.0,163085187.0,-1.0,follistatin-like 5 [Source:HGNC Symbol;Acc:21386],0.0,1.0,1.0,1.0
19,19,PRKD1,0.0064176889184064,BipolarDisorder,ENSG00000184304,Tier 1,PRKD1,14,30045687.0,30661104.0,-1.0,protein kinase D1 [Source:HGNC Symbol;Acc:9407],2.0,1.0,1.0,1.0
19,19,PRKD1,0.0064176889184064,Schizophrenia,ENSG00000184304,Tier 1,PRKD1,14,30045687.0,30661104.0,-1.0,protein kinase D1 [Source:HGNC Symbol;Acc:9407],2.0,1.0,1.0,1.0
20,20,DCC,0.0057822326516042,AnorexiaNervosa,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
20,20,DCC,0.0057822326516042,BipolarDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
20,20,DCC,0.0057822326516042,MajorDepressiveDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
20,20,DCC,0.0057822326516042,NeuroticDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
20,20,DCC,0.0057822326516042,OCD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
20,20,DCC,0.0057822326516042,Schizophrenia,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
20,20,DCC,0.0057822326516042,TouretteSyndrome,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
20,20,DCC,0.0057822326516042,UnipolarDepression,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
21,21,TGFBR2,0.0055437003087157,MigraineDisorder,ENSG00000163513,Tier 1,TGFBR2,3,30647994.0,30735634.0,1.0,"transforming growth factor, beta receptor II (70/80kDa) [Source:HGNC Symbol;Acc:11773]",1.0,1.0,1.0,1.0
21,21,TGFBR2,0.0055437003087157,Schizophrenia,ENSG00000163513,Tier 1,TGFBR2,3,30647994.0,30735634.0,1.0,"transforming growth factor, beta receptor II (70/80kDa) [Source:HGNC Symbol;Acc:11773]",1.0,1.0,1.0,1.0
23,23,PDCD1,0.0053267901949744,BrainAneurysm,ENSG00000188389,Tier 1,PDCD1,2,242792033.0,242801060.0,-1.0,programmed cell death 1 [Source:HGNC Symbol;Acc:8760],0.0,1.0,1.0,1.0
23,23,PDCD1,0.0053267901949744,MS,ENSG00000188389,Tier 1,PDCD1,2,242792033.0,242801060.0,-1.0,programmed cell death 1 [Source:HGNC Symbol;Acc:8760],0.0,1.0,1.0,1.0
24,24,IL2RA,0.0052385757407805,MS,ENSG00000134460,Tier 1,IL2RA,10,6052652.0,6104288.0,-1.0,"interleukin 2 receptor, alpha [Source:HGNC Symbol;Acc:6008]",16.0,1.0,1.0,1.0
25,25,TNFSF14,0.0051594647349994,MS,ENSG00000125735,Tier 1,TNFSF14,19,6663148.0,6670599.0,-1.0,"tumor necrosis factor (ligand) superfamily, member 14 [Source:HGNC Symbol;Acc:11930]",1.0,1.0,1.0,1.0
26,26,EPHA1,0.0045442023738609,AD,ENSG00000146904,Tier 1,EPHA1,7,143087382.0,143105985.0,-1.0,EPH receptor A1 [Source:HGNC Symbol;Acc:3385],1.0,1.0,1.0,1.0
27,27,GRIA1,0.0045366656753091,AnorexiaNervosa,ENSG00000155511,Tier 1,GRIA1,5,152869175.0,153193429.0,1.0,"glutamate receptor, ionotropic, AMPA 1 [Source:HGNC Symbol;Acc:4571]",1.0,1.0,1.0,1.0
27,27,GRIA1,0.0045366656753091,BipolarDisorder,ENSG00000155511,Tier 1,GRIA1,5,152869175.0,153193429.0,1.0,"glutamate receptor, ionotropic, AMPA 1 [Source:HGNC Symbol;Acc:4571]",1.0,1.0,1.0,1.0
27,27,GRIA1,0.0045366656753091,OCD,ENSG00000155511,Tier 1,GRIA1,5,152869175.0,153193429.0,1.0,"glutamate receptor, ionotropic, AMPA 1 [Source:HGNC Symbol;Acc:4571]",1.0,1.0,1.0,1.0
27,27,GRIA1,0.0045366656753091,Schizophrenia,ENSG00000155511,Tier 1,GRIA1,5,152869175.0,153193429.0,1.0,"glutamate receptor, ionotropic, AMPA 1 [Source:HGNC Symbol;Acc:4571]",1.0,1.0,1.0,1.0
27,27,GRIA1,0.0045366656753091,TouretteSyndrome,ENSG00000155511,Tier 1,GRIA1,5,152869175.0,153193429.0,1.0,"glutamate receptor, ionotropic, AMPA 1 [Source:HGNC Symbol;Acc:4571]",1.0,1.0,1.0,1.0
27,27,GRIA1,0.0045366656753091,UnipolarDepression,ENSG00000155511,Tier 1,GRIA1,5,152869175.0,153193429.0,1.0,"glutamate receptor, ionotropic, AMPA 1 [Source:HGNC Symbol;Acc:4571]",1.0,1.0,1.0,1.0
28,28,S1PR1,0.0042045231978397,PD,ENSG00000170989,Tier 1,S1PR1,1,101702444.0,101707074.0,1.0,sphingosine-1-phosphate receptor 1 [Source:HGNC Symbol;Acc:3165],0.0,1.0,1.0,1.0
29,29,CD47,0.0041516409983115,BipolarDisorder,ENSG00000196776,Tier 3B,CD47,3,107762145.0,107809872.0,-1.0,CD47 molecule [Source:HGNC Symbol;Acc:1682],0.0,1.0,1.0,1.0
29,29,CD47,0.0041516409983115,TouretteSyndrome,ENSG00000196776,Tier 3B,CD47,3,107762145.0,107809872.0,-1.0,CD47 molecule [Source:HGNC Symbol;Acc:1682],0.0,1.0,1.0,1.0
31,31,MPO,0.0037271366459905,AD,ENSG00000005381,Tier 1,MPO,17,56347217.0,56358296.0,-1.0,myeloperoxidase [Source:HGNC Symbol;Acc:7218],1.0,1.0,1.0,1.0
33,33,MAP4K4,0.0035647410375156,PD,ENSG00000071054,Tier 1,MAP4K4,2,102313312.0,102511149.0,1.0,mitogen-activated protein kinase kinase kinase kinase 4 [Source:HGNC Symbol;Acc:6866],0.0,1.0,1.0,1.0
34,34,SEMA6D,0.003402417887672,AnorexiaNervosa,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
34,34,SEMA6D,0.003402417887672,MajorDepressiveDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
34,34,SEMA6D,0.003402417887672,RestlessLeg,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
34,34,SEMA6D,0.003402417887672,Schizophrenia,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
34,34,SEMA6D,0.003402417887672,UnipolarDepression,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
35,35,DCLK3,0.0033983935185898,AnorexiaNervosa,ENSG00000163673,Tier 1,DCLK3,3,36753913.0,36781352.0,-1.0,doublecortin-like kinase 3 [Source:HGNC Symbol;Acc:19005],0.0,1.0,1.0,1.0
35,35,DCLK3,0.0033983935185898,BipolarDisorder,ENSG00000163673,Tier 1,DCLK3,3,36753913.0,36781352.0,-1.0,doublecortin-like kinase 3 [Source:HGNC Symbol;Acc:19005],0.0,1.0,1.0,1.0
35,35,DCLK3,0.0033983935185898,OCD,ENSG00000163673,Tier 1,DCLK3,3,36753913.0,36781352.0,-1.0,doublecortin-like kinase 3 [Source:HGNC Symbol;Acc:19005],0.0,1.0,1.0,1.0
35,35,DCLK3,0.0033983935185898,Schizophrenia,ENSG00000163673,Tier 1,DCLK3,3,36753913.0,36781352.0,-1.0,doublecortin-like kinase 3 [Source:HGNC Symbol;Acc:19005],0.0,1.0,1.0,1.0
35,35,DCLK3,0.0033983935185898,TouretteSyndrome,ENSG00000163673,Tier 1,DCLK3,3,36753913.0,36781352.0,-1.0,doublecortin-like kinase 3 [Source:HGNC Symbol;Acc:19005],0.0,1.0,1.0,1.0
35,35,DCLK3,0.0033983935185898,UnipolarDepression,ENSG00000163673,Tier 1,DCLK3,3,36753913.0,36781352.0,-1.0,doublecortin-like kinase 3 [Source:HGNC Symbol;Acc:19005],0.0,1.0,1.0,1.0
40,40,ATM,0.0028821629953061,PD,ENSG00000149311,Tier 2,ATM,11,108093211.0,108239829.0,1.0,ataxia telangiectasia mutated [Source:HGNC Symbol;Acc:795],3.0,1.0,1.0,1.0
42,42,TYK2,0.0028566704839114,MS,ENSG00000105397,Tier 1,TYK2,19,10461209.0,10491352.0,-1.0,tyrosine kinase 2 [Source:HGNC Symbol;Acc:12440],7.0,1.0,1.0,1.0
43,43,TGFB1,0.0028294577272905,MigraineDisorder,ENSG00000105329,Tier 1,TGFB1,19,41807492.0,41859816.0,-1.0,"transforming growth factor, beta 1 [Source:HGNC Symbol;Acc:11766]",1.0,1.0,1.0,1.0
44,44,MAPK1,0.0027887953557573,MS,ENSG00000100030,Tier 1,MAPK1,22,22108789.0,22221970.0,-1.0,mitogen-activated protein kinase 1 [Source:HGNC Symbol;Acc:6871],1.0,1.0,1.0,1.0
45,45,FGFR3,0.0027493765620436,PartialEpilepsy,ENSG00000068078,Tier 1,FGFR3,4,1795034.0,1810599.0,1.0,fibroblast growth factor receptor 3 [Source:HGNC Symbol;Acc:3690],0.0,1.0,1.0,1.0
46,46,PLA2G6,0.0027031467553837,PD,ENSG00000184381,Tier 2,PLA2G6,22,38507502.0,38601697.0,-1.0,"phospholipase A2, group VI (cytosolic, calcium-independent) [Source:HGNC Symbol;Acc:9039]",4.0,1.0,1.0,1.0
47,47,LGI1,0.002685996198606,PartialEpilepsy,ENSG00000108231,Tier 3B,LGI1,10,95517566.0,95557916.0,1.0,"leucine-rich, glioma inactivated 1 [Source:HGNC Symbol;Acc:6572]",0.0,1.0,1.0,1.0
48,48,LRFN5,0.002685996198606,AnorexiaNervosa,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
48,48,LRFN5,0.002685996198606,BipolarDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
48,48,LRFN5,0.002685996198606,MajorDepressiveDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
48,48,LRFN5,0.002685996198606,OCD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
48,48,LRFN5,0.002685996198606,Schizophrenia,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
48,48,LRFN5,0.002685996198606,TouretteSyndrome,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
48,48,LRFN5,0.002685996198606,UnipolarDepression,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
49,49,FES,0.0026571782056069,AnorexiaNervosa,ENSG00000182511,Tier 2,FES,15,91426925.0,91439006.0,1.0,feline sarcoma oncogene [Source:HGNC Symbol;Acc:3657],4.0,1.0,1.0,1.0
49,49,FES,0.0026571782056069,BipolarDisorder,ENSG00000182511,Tier 2,FES,15,91426925.0,91439006.0,1.0,feline sarcoma oncogene [Source:HGNC Symbol;Acc:3657],4.0,1.0,1.0,1.0
49,49,FES,0.0026571782056069,MajorDepressiveDisorder,ENSG00000182511,Tier 2,FES,15,91426925.0,91439006.0,1.0,feline sarcoma oncogene [Source:HGNC Symbol;Acc:3657],4.0,1.0,1.0,1.0
49,49,FES,0.0026571782056069,OCD,ENSG00000182511,Tier 2,FES,15,91426925.0,91439006.0,1.0,feline sarcoma oncogene [Source:HGNC Symbol;Acc:3657],4.0,1.0,1.0,1.0
49,49,FES,0.0026571782056069,Schizophrenia,ENSG00000182511,Tier 2,FES,15,91426925.0,91439006.0,1.0,feline sarcoma oncogene [Source:HGNC Symbol;Acc:3657],4.0,1.0,1.0,1.0
49,49,FES,0.0026571782056069,TouretteSyndrome,ENSG00000182511,Tier 2,FES,15,91426925.0,91439006.0,1.0,feline sarcoma oncogene [Source:HGNC Symbol;Acc:3657],4.0,1.0,1.0,1.0
49,49,FES,0.0026571782056069,UnipolarDepression,ENSG00000182511,Tier 2,FES,15,91426925.0,91439006.0,1.0,feline sarcoma oncogene [Source:HGNC Symbol;Acc:3657],4.0,1.0,1.0,1.0
50,50,INPP5D,0.0026510275151558,AD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
51,51,SCN9A,0.0026328209266923,PartialEpilepsy,ENSG00000169432,Tier 1,SCN9A,2,167051695.0,167232503.0,-1.0,"sodium channel, voltage-gated, type IX, alpha subunit [Source:HGNC Symbol;Acc:10597]",0.0,1.0,1.0,1.0
52,52,GRIN2A,0.0026042989667742,AnorexiaNervosa,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,1.0,1.0
52,52,GRIN2A,0.0026042989667742,BipolarDisorder,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,1.0,1.0
52,52,GRIN2A,0.0026042989667742,OCD,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,1.0,1.0
52,52,GRIN2A,0.0026042989667742,PartialEpilepsy,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,1.0,1.0
52,52,GRIN2A,0.0026042989667742,Schizophrenia,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,1.0,1.0
52,52,GRIN2A,0.0026042989667742,TouretteSyndrome,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,1.0,1.0
52,52,GRIN2A,0.0026042989667742,UnipolarDepression,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,1.0,1.0
53,53,NEGR1,0.0025841525115073,AnorexiaNervosa,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,1.0,1.0,1.0
53,53,NEGR1,0.0025841525115073,BipolarDisorder,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,1.0,1.0,1.0
53,53,NEGR1,0.0025841525115073,MajorDepressiveDisorder,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,1.0,1.0,1.0
53,53,NEGR1,0.0025841525115073,OCD,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,1.0,1.0,1.0
53,53,NEGR1,0.0025841525115073,Schizophrenia,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,1.0,1.0,1.0
53,53,NEGR1,0.0025841525115073,TouretteSyndrome,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,1.0,1.0,1.0
53,53,NEGR1,0.0025841525115073,UnipolarDepression,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,1.0,1.0,1.0
54,54,NMUR2,0.0025841525115073,AnorexiaNervosa,ENSG00000132911,Tier 3B,NMUR2,5,151771093.0,151812929.0,-1.0,neuromedin U receptor 2 [Source:HGNC Symbol;Acc:16454],0.0,1.0,1.0,1.0
54,54,NMUR2,0.0025841525115073,BipolarDisorder,ENSG00000132911,Tier 3B,NMUR2,5,151771093.0,151812929.0,-1.0,neuromedin U receptor 2 [Source:HGNC Symbol;Acc:16454],0.0,1.0,1.0,1.0
54,54,NMUR2,0.0025841525115073,MigraineDisorder,ENSG00000132911,Tier 3B,NMUR2,5,151771093.0,151812929.0,-1.0,neuromedin U receptor 2 [Source:HGNC Symbol;Acc:16454],0.0,1.0,1.0,1.0
54,54,NMUR2,0.0025841525115073,OCD,ENSG00000132911,Tier 3B,NMUR2,5,151771093.0,151812929.0,-1.0,neuromedin U receptor 2 [Source:HGNC Symbol;Acc:16454],0.0,1.0,1.0,1.0
54,54,NMUR2,0.0025841525115073,Schizophrenia,ENSG00000132911,Tier 3B,NMUR2,5,151771093.0,151812929.0,-1.0,neuromedin U receptor 2 [Source:HGNC Symbol;Acc:16454],0.0,1.0,1.0,1.0
54,54,NMUR2,0.0025841525115073,TouretteSyndrome,ENSG00000132911,Tier 3B,NMUR2,5,151771093.0,151812929.0,-1.0,neuromedin U receptor 2 [Source:HGNC Symbol;Acc:16454],0.0,1.0,1.0,1.0
54,54,NMUR2,0.0025841525115073,UnipolarDepression,ENSG00000132911,Tier 3B,NMUR2,5,151771093.0,151812929.0,-1.0,neuromedin U receptor 2 [Source:HGNC Symbol;Acc:16454],0.0,1.0,1.0,1.0
55,55,CHRNA7,0.0024947279184736,PartialEpilepsy,ENSG00000175344,Tier 1,CHRNA7,15,32322691.0,32464722.0,1.0,"cholinergic receptor, nicotinic, alpha 7 (neuronal) [Source:HGNC Symbol;Acc:1960]",0.0,1.0,1.0,1.0
56,56,CD86,0.0024908696091428,MS,ENSG00000114013,Tier 1,CD86,3,121774213.0,121839983.0,1.0,CD86 molecule [Source:HGNC Symbol;Acc:1705],1.0,1.0,1.0,1.0
57,57,SYNJ1,0.0024384369316029,PD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
58,58,PLCG2,0.0024281172761519,AD,ENSG00000197943,Tier 2,PLCG2,16,81772702.0,81991899.0,1.0,"phospholipase C, gamma 2 (phosphatidylinositol-specific) [Source:HGNC Symbol;Acc:9066]",0.0,1.0,1.0,1.0
59,59,CLEC2D,0.0024199822632386,MS,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
61,61,CNTN4,0.0023776344000159,AnorexiaNervosa,ENSG00000144619,Tier 3A,CNTN4,3,2140497.0,3099645.0,1.0,contactin 4 [Source:HGNC Symbol;Acc:2174],2.0,1.0,1.0,1.0
61,61,CNTN4,0.0023776344000159,BipolarDisorder,ENSG00000144619,Tier 3A,CNTN4,3,2140497.0,3099645.0,1.0,contactin 4 [Source:HGNC Symbol;Acc:2174],2.0,1.0,1.0,1.0
61,61,CNTN4,0.0023776344000159,OCD,ENSG00000144619,Tier 3A,CNTN4,3,2140497.0,3099645.0,1.0,contactin 4 [Source:HGNC Symbol;Acc:2174],2.0,1.0,1.0,1.0
61,61,CNTN4,0.0023776344000159,Schizophrenia,ENSG00000144619,Tier 3A,CNTN4,3,2140497.0,3099645.0,1.0,contactin 4 [Source:HGNC Symbol;Acc:2174],2.0,1.0,1.0,1.0
61,61,CNTN4,0.0023776344000159,TouretteSyndrome,ENSG00000144619,Tier 3A,CNTN4,3,2140497.0,3099645.0,1.0,contactin 4 [Source:HGNC Symbol;Acc:2174],2.0,1.0,1.0,1.0
61,61,CNTN4,0.0023776344000159,UnipolarDepression,ENSG00000144619,Tier 3A,CNTN4,3,2140497.0,3099645.0,1.0,contactin 4 [Source:HGNC Symbol;Acc:2174],2.0,1.0,1.0,1.0
62,62,CD33,0.0023161056466308,AD,ENSG00000105383,Tier 1,CD33,19,51728320.0,51747115.0,1.0,CD33 molecule [Source:HGNC Symbol;Acc:1659],1.0,1.0,1.0,1.0
66,66,SCN1A,0.0020708614087032,MigraineDisorder,ENSG00000144285,Tier 1,SCN1A,2,166845670.0,166984523.0,-1.0,"sodium channel, voltage-gated, type I, alpha subunit [Source:HGNC Symbol;Acc:10585]",6.0,1.0,1.0,1.0
66,66,SCN1A,0.0020708614087032,MigraineWithAura,ENSG00000144285,Tier 1,SCN1A,2,166845670.0,166984523.0,-1.0,"sodium channel, voltage-gated, type I, alpha subunit [Source:HGNC Symbol;Acc:10585]",6.0,1.0,1.0,1.0
66,66,SCN1A,0.0020708614087032,PartialEpilepsy,ENSG00000144285,Tier 1,SCN1A,2,166845670.0,166984523.0,-1.0,"sodium channel, voltage-gated, type I, alpha subunit [Source:HGNC Symbol;Acc:10585]",6.0,1.0,1.0,1.0
67,67,SCN2A,0.0020708614087032,BipolarDisorder,ENSG00000136531,Tier 1,SCN2A,2,166095912.0,166248818.0,1.0,"sodium channel, voltage-gated, type II, alpha subunit [Source:HGNC Symbol;Acc:10588]",1.0,1.0,1.0,1.0
67,67,SCN2A,0.0020708614087032,PartialEpilepsy,ENSG00000136531,Tier 1,SCN2A,2,166095912.0,166248818.0,1.0,"sodium channel, voltage-gated, type II, alpha subunit [Source:HGNC Symbol;Acc:10588]",1.0,1.0,1.0,1.0
67,67,SCN2A,0.0020708614087032,PD,ENSG00000136531,Tier 1,SCN2A,2,166095912.0,166248818.0,1.0,"sodium channel, voltage-gated, type II, alpha subunit [Source:HGNC Symbol;Acc:10588]",1.0,1.0,1.0,1.0
69,69,CD58,0.0020584914415673,MS,ENSG00000116815,Tier 3A,CD58,1,117057157.0,117113661.0,-1.0,CD58 molecule [Source:HGNC Symbol;Acc:1688],3.0,1.0,1.0,1.0
74,74,LCK,0.0018884070166008,MS,ENSG00000182866,Tier 1,LCK,1,32716840.0,32751766.0,1.0,lymphocyte-specific protein tyrosine kinase [Source:HGNC Symbol;Acc:6524],0.0,1.0,1.0,1.0
76,76,SLC2A1,0.0018534383081556,MigraineDisorder,ENSG00000117394,Tier 2,SLC2A1,1,43391052.0,43424530.0,-1.0,"solute carrier family 2 (facilitated glucose transporter), member 1 [Source:HGNC Symbol;Acc:11005]",0.0,1.0,1.0,1.0
76,76,SLC2A1,0.0018534383081556,PartialEpilepsy,ENSG00000117394,Tier 2,SLC2A1,1,43391052.0,43424530.0,-1.0,"solute carrier family 2 (facilitated glucose transporter), member 1 [Source:HGNC Symbol;Acc:11005]",0.0,1.0,1.0,1.0
77,77,CR1,0.0018514771337288,AD,ENSG00000203710,Tier 3A,CR1,1,207669492.0,207813992.0,1.0,complement component (3b/4b) receptor 1 (Knops blood group) [Source:HGNC Symbol;Acc:2334],8.0,1.0,1.0,1.0
81,81,ANG,0.0018401919508063,ALS,ENSG00000214274,Tier 3B,ANG,14,21152336.0,21167130.0,1.0,"angiogenin, ribonuclease, RNase A family, 5 [Source:HGNC Symbol;Acc:483]",0.0,1.0,1.0,1.0
81,81,ANG,0.0018401919508063,FrontotemporalDementia,ENSG00000214274,Tier 3B,ANG,14,21152336.0,21167130.0,1.0,"angiogenin, ribonuclease, RNase A family, 5 [Source:HGNC Symbol;Acc:483]",0.0,1.0,1.0,1.0
84,84,ACE,0.0017912161700943,AD,ENSG00000159640,Tier 1,ACE,17,61554422.0,61599205.0,1.0,angiotensin I converting enzyme [Source:HGNC Symbol;Acc:2707],13.0,1.0,1.0,1.0
84,84,ACE,0.0017912161700943,IntracranialHemorrhage,ENSG00000159640,Tier 1,ACE,17,61554422.0,61599205.0,1.0,angiotensin I converting enzyme [Source:HGNC Symbol;Acc:2707],13.0,1.0,1.0,1.0
85,85,ESR2,0.0017912161700943,AnorexiaNervosa,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,1.0,1.0
85,85,ESR2,0.0017912161700943,BipolarDisorder,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,1.0,1.0
85,85,ESR2,0.0017912161700943,MajorDepressiveDisorder,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,1.0,1.0
85,85,ESR2,0.0017912161700943,OCD,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,1.0,1.0
85,85,ESR2,0.0017912161700943,Schizophrenia,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,1.0,1.0
85,85,ESR2,0.0017912161700943,TouretteSyndrome,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,1.0,1.0
85,85,ESR2,0.0017912161700943,UnipolarDepression,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,1.0,1.0
86,86,CHRNA4,0.0017897283283835,ALS,ENSG00000101204,Tier 1,CHRNA4,20,61975420.0,62009753.0,-1.0,"cholinergic receptor, nicotinic, alpha 4 (neuronal) [Source:HGNC Symbol;Acc:1958]",0.0,1.0,1.0,1.0
86,86,CHRNA4,0.0017897283283835,FrontotemporalDementia,ENSG00000101204,Tier 1,CHRNA4,20,61975420.0,62009753.0,-1.0,"cholinergic receptor, nicotinic, alpha 4 (neuronal) [Source:HGNC Symbol;Acc:1958]",0.0,1.0,1.0,1.0
86,86,CHRNA4,0.0017897283283835,PartialEpilepsy,ENSG00000101204,Tier 1,CHRNA4,20,61975420.0,62009753.0,-1.0,"cholinergic receptor, nicotinic, alpha 4 (neuronal) [Source:HGNC Symbol;Acc:1958]",0.0,1.0,1.0,1.0
88,88,IL22RA2,0.0017708291952823,MS,ENSG00000164485,Tier 3A,IL22RA2,6,137464968.0,137494785.0,-1.0,"interleukin 22 receptor, alpha 2 [Source:HGNC Symbol;Acc:14901]",0.0,1.0,1.0,1.0
89,89,LINGO1,0.0017699115044247,EssentialTremor,ENSG00000169783,Tier 1,LINGO1,15,77905369.0,78113242.0,-1.0,leucine rich repeat and Ig domain containing 1 [Source:HGNC Symbol;Acc:21205],1.0,1.0,1.0,1.0
89,89,LINGO1,0.0017699115044247,NeuroticDisorder,ENSG00000169783,Tier 1,LINGO1,15,77905369.0,78113242.0,-1.0,leucine rich repeat and Ig domain containing 1 [Source:HGNC Symbol;Acc:21205],1.0,1.0,1.0,1.0
89,89,LINGO1,0.0017699115044247,Schizophrenia,ENSG00000169783,Tier 1,LINGO1,15,77905369.0,78113242.0,-1.0,leucine rich repeat and Ig domain containing 1 [Source:HGNC Symbol;Acc:21205],1.0,1.0,1.0,1.0
89,89,LINGO1,0.0017699115044247,UnipolarDepression,ENSG00000169783,Tier 1,LINGO1,15,77905369.0,78113242.0,-1.0,leucine rich repeat and Ig domain containing 1 [Source:HGNC Symbol;Acc:21205],1.0,1.0,1.0,1.0
90,90,SORL1,0.0017699115044247,AD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
92,92,MAPT,0.0017699115044247,AD,ENSG00000186868,Tier 1,MAPT,17,43971748.0,44105700.0,1.0,microtubule-associated protein tau [Source:HGNC Symbol;Acc:6893],19.0,1.0,1.0,1.0
92,92,MAPT,0.0017699115044247,FrontotemporalDementia,ENSG00000186868,Tier 1,MAPT,17,43971748.0,44105700.0,1.0,microtubule-associated protein tau [Source:HGNC Symbol;Acc:6893],19.0,1.0,1.0,1.0
92,92,MAPT,0.0017699115044247,NeuroticDisorder,ENSG00000186868,Tier 1,MAPT,17,43971748.0,44105700.0,1.0,microtubule-associated protein tau [Source:HGNC Symbol;Acc:6893],19.0,1.0,1.0,1.0
92,92,MAPT,0.0017699115044247,PD,ENSG00000186868,Tier 1,MAPT,17,43971748.0,44105700.0,1.0,microtubule-associated protein tau [Source:HGNC Symbol;Acc:6893],19.0,1.0,1.0,1.0
92,92,MAPT,0.0017699115044247,ProgressiveSupranuclearPalsy,ENSG00000186868,Tier 1,MAPT,17,43971748.0,44105700.0,1.0,microtubule-associated protein tau [Source:HGNC Symbol;Acc:6893],19.0,1.0,1.0,1.0
93,93,ATP2A2,0.0017699115044247,AnorexiaNervosa,ENSG00000174437,Tier 3B,ATP2A2,12,110718561.0,110788898.0,1.0,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 [Source:HGNC Symbol;Acc:812]",2.0,1.0,1.0,1.0
93,93,ATP2A2,0.0017699115044247,BipolarDisorder,ENSG00000174437,Tier 3B,ATP2A2,12,110718561.0,110788898.0,1.0,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 [Source:HGNC Symbol;Acc:812]",2.0,1.0,1.0,1.0
93,93,ATP2A2,0.0017699115044247,OCD,ENSG00000174437,Tier 3B,ATP2A2,12,110718561.0,110788898.0,1.0,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 [Source:HGNC Symbol;Acc:812]",2.0,1.0,1.0,1.0
93,93,ATP2A2,0.0017699115044247,Schizophrenia,ENSG00000174437,Tier 3B,ATP2A2,12,110718561.0,110788898.0,1.0,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 [Source:HGNC Symbol;Acc:812]",2.0,1.0,1.0,1.0
93,93,ATP2A2,0.0017699115044247,TouretteSyndrome,ENSG00000174437,Tier 3B,ATP2A2,12,110718561.0,110788898.0,1.0,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 [Source:HGNC Symbol;Acc:812]",2.0,1.0,1.0,1.0
93,93,ATP2A2,0.0017699115044247,UnipolarDepression,ENSG00000174437,Tier 3B,ATP2A2,12,110718561.0,110788898.0,1.0,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 [Source:HGNC Symbol;Acc:812]",2.0,1.0,1.0,1.0
94,94,CNTNAP2,0.0017699115044247,AD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
94,94,CNTNAP2,0.0017699115044247,PartialEpilepsy,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
100,100,CALCA,0.0017078828867227,MigraineDisorder,ENSG00000110680,Tier 1,CALCA,11,14988214.0,14993900.0,-1.0,calcitonin-related polypeptide alpha [Source:HGNC Symbol;Acc:1437],0.0,1.0,1.0,1.0
110,110,PTPRF,0.0015880665231703,AnorexiaNervosa,ENSG00000142949,Tier 2,PTPRF,1,43990858.0,44089343.0,1.0,"protein tyrosine phosphatase, receptor type, F [Source:HGNC Symbol;Acc:9670]",2.0,1.0,1.0,1.0
110,110,PTPRF,0.0015880665231703,BipolarDisorder,ENSG00000142949,Tier 2,PTPRF,1,43990858.0,44089343.0,1.0,"protein tyrosine phosphatase, receptor type, F [Source:HGNC Symbol;Acc:9670]",2.0,1.0,1.0,1.0
110,110,PTPRF,0.0015880665231703,OCD,ENSG00000142949,Tier 2,PTPRF,1,43990858.0,44089343.0,1.0,"protein tyrosine phosphatase, receptor type, F [Source:HGNC Symbol;Acc:9670]",2.0,1.0,1.0,1.0
110,110,PTPRF,0.0015880665231703,Schizophrenia,ENSG00000142949,Tier 2,PTPRF,1,43990858.0,44089343.0,1.0,"protein tyrosine phosphatase, receptor type, F [Source:HGNC Symbol;Acc:9670]",2.0,1.0,1.0,1.0
110,110,PTPRF,0.0015880665231703,TouretteSyndrome,ENSG00000142949,Tier 2,PTPRF,1,43990858.0,44089343.0,1.0,"protein tyrosine phosphatase, receptor type, F [Source:HGNC Symbol;Acc:9670]",2.0,1.0,1.0,1.0
110,110,PTPRF,0.0015880665231703,UnipolarDepression,ENSG00000142949,Tier 2,PTPRF,1,43990858.0,44089343.0,1.0,"protein tyrosine phosphatase, receptor type, F [Source:HGNC Symbol;Acc:9670]",2.0,1.0,1.0,1.0
112,112,PLCE1,0.0015845355922552,BrainAneurysm,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
112,112,PLCE1,0.0015845355922552,MigraineDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
113,113,CAMK2D,0.0015771200712427,PD,ENSG00000145349,Tier 1,CAMK2D,4,114372188.0,114683083.0,-1.0,calcium/calmodulin-dependent protein kinase II delta [Source:HGNC Symbol;Acc:1462],1.0,1.0,1.0,1.0
114,114,STK39,0.0015769276390821,PD,ENSG00000198648,Tier 2,STK39,2,168810530.0,169104651.0,-1.0,serine threonine kinase 39 [Source:HGNC Symbol;Acc:17717],2.0,1.0,1.0,1.0
120,120,CSF3,0.0015358538221824,BipolarDisorder,ENSG00000108342,Tier 3A,CSF3,17,38171614.0,38174066.0,1.0,colony stimulating factor 3 (granulocyte) [Source:HGNC Symbol;Acc:2438],8.0,1.0,1.0,1.0
122,122,MAPK3,0.0015085863395152,MS,ENSG00000102882,Tier 1,MAPK3,16,30125426.0,30134827.0,-1.0,mitogen-activated protein kinase 3 [Source:HGNC Symbol;Acc:6877],1.0,1.0,1.0,1.0
124,124,EFNA5,0.00147130899774,BipolarDisorder,ENSG00000184349,Tier 3A,EFNA5,5,106712590.0,107006596.0,-1.0,ephrin-A5 [Source:HGNC Symbol;Acc:3225],0.0,1.0,1.0,1.0
124,124,EFNA5,0.00147130899774,Schizophrenia,ENSG00000184349,Tier 3A,EFNA5,5,106712590.0,107006596.0,-1.0,ephrin-A5 [Source:HGNC Symbol;Acc:3225],0.0,1.0,1.0,1.0
124,124,EFNA5,0.00147130899774,UnipolarDepression,ENSG00000184349,Tier 3A,EFNA5,5,106712590.0,107006596.0,-1.0,ephrin-A5 [Source:HGNC Symbol;Acc:3225],0.0,1.0,1.0,1.0
136,136,TREM2,0.0013992646347512,FrontotemporalDementia,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
138,138,CD28,0.0013985288480329,MS,ENSG00000178562,Tier 1,CD28,2,204571198.0,204603635.0,1.0,CD28 molecule [Source:HGNC Symbol;Acc:1653],2.0,1.0,1.0,1.0
139,139,TNFRSF1A,0.0013969017670206,MS,ENSG00000067182,Tier 1,TNFRSF1A,12,6437923.0,6451280.0,-1.0,"tumor necrosis factor receptor superfamily, member 1A [Source:HGNC Symbol;Acc:11916]",3.0,1.0,1.0,1.0
142,142,SLAMF1,0.0013905430073205,MS,ENSG00000117090,Tier 3A,SLAMF1,1,160577890.0,160617085.0,-1.0,signaling lymphocytic activation molecule family member 1 [Source:HGNC Symbol;Acc:10903],0.0,1.0,1.0,1.0
143,143,IL6R,0.0013848585257931,AD,ENSG00000160712,Tier 1,IL6R,1,154377669.0,154441926.0,1.0,interleukin 6 receptor [Source:HGNC Symbol;Acc:6019],9.0,1.0,1.0,1.0
148,148,BTN1A1,0.0013627910008834,BipolarDisorder,ENSG00000124557,Tier 3A,BTN1A1,6,26501449.0,26510650.0,1.0,"butyrophilin, subfamily 1, member A1 [Source:HGNC Symbol;Acc:1135]",1.0,1.0,1.0,1.0
148,148,BTN1A1,0.0013627910008834,UnipolarDepression,ENSG00000124557,Tier 3A,BTN1A1,6,26501449.0,26510650.0,1.0,"butyrophilin, subfamily 1, member A1 [Source:HGNC Symbol;Acc:1135]",1.0,1.0,1.0,1.0
152,152,IL21,0.0013574316912208,BipolarDisorder,ENSG00000138684,Tier 3A,IL21,4,123533783.0,123542224.0,-1.0,interleukin 21 [Source:HGNC Symbol;Acc:6005],9.0,1.0,1.0,1.0
153,153,TBK1,0.0013535362754775,ALS,ENSG00000183735,Tier 1,TBK1,12,64845660.0,64895888.0,1.0,TANK-binding kinase 1 [Source:HGNC Symbol;Acc:11584],0.0,1.0,1.0,1.0
153,153,TBK1,0.0013535362754775,FrontotemporalDementia,ENSG00000183735,Tier 1,TBK1,12,64845660.0,64895888.0,1.0,TANK-binding kinase 1 [Source:HGNC Symbol;Acc:11584],0.0,1.0,1.0,1.0
158,158,ITGB7,0.0013535123728126,Schizophrenia,ENSG00000139626,Tier 1,ITGB7,12,53585102.0,53601091.0,-1.0,"integrin, beta 7 [Source:HGNC Symbol;Acc:6162]",0.0,1.0,1.0,1.0
167,167,PDGFD,0.001336777682743,MigraineDisorder,ENSG00000170962,Tier 3A,PDGFD,11,103777914.0,104035107.0,-1.0,platelet derived growth factor D [Source:HGNC Symbol;Acc:30620],0.0,1.0,1.0,1.0
171,171,PTK2B,0.0013173244122207,AD,ENSG00000120899,Tier 1,PTK2B,8,27168999.0,27316903.0,1.0,protein tyrosine kinase 2 beta [Source:HGNC Symbol;Acc:9612],1.0,1.0,1.0,1.0
175,175,IL12B,0.0013026339480238,MS,ENSG00000113302,Tier 1,IL12B,5,158741791.0,158757895.0,-1.0,"interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) [Source:HGNC Symbol;Acc:5970]",5.0,1.0,1.0,1.0
175,175,IL12B,0.0013026339480238,UnipolarDepression,ENSG00000113302,Tier 1,IL12B,5,158741791.0,158757895.0,-1.0,"interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) [Source:HGNC Symbol;Acc:5970]",5.0,1.0,1.0,1.0
177,177,CD8B,0.0012893132894858,ProgressiveSupranuclearPalsy,ENSG00000172116,Tier 3A,CD8B,2,87042462.0,87089047.0,-1.0,CD8b molecule [Source:HGNC Symbol;Acc:1707],1.0,1.0,1.0,1.0
184,184,IL2,0.0012694067486147,BipolarDisorder,ENSG00000109471,Tier 1,IL2,4,123372625.0,123377880.0,-1.0,interleukin 2 [Source:HGNC Symbol;Acc:6001],9.0,1.0,1.0,1.0
184,184,IL2,0.0012694067486147,UnipolarDepression,ENSG00000109471,Tier 1,IL2,4,123372625.0,123377880.0,-1.0,interleukin 2 [Source:HGNC Symbol;Acc:6001],9.0,1.0,1.0,1.0
187,187,JAK1,0.0012575637435622,MS,ENSG00000162434,Tier 1,JAK1,1,65298912.0,65432187.0,-1.0,Janus kinase 1 [Source:HGNC Symbol;Acc:6190],0.0,1.0,1.0,1.0
188,188,CHRNB2,0.0012340734995183,PartialEpilepsy,ENSG00000160716,Tier 1,CHRNB2,1,154540257.0,154552502.0,1.0,"cholinergic receptor, nicotinic, beta 2 (neuronal) [Source:HGNC Symbol;Acc:1962]",0.0,1.0,1.0,1.0
189,189,CHRNA3,0.0012340734995183,ALS,ENSG00000080644,Tier 1,CHRNA3,15,78885394.0,78913637.0,-1.0,"cholinergic receptor, nicotinic, alpha 3 (neuronal) [Source:HGNC Symbol;Acc:1957]",28.0,1.0,1.0,1.0
189,189,CHRNA3,0.0012340734995183,AnorexiaNervosa,ENSG00000080644,Tier 1,CHRNA3,15,78885394.0,78913637.0,-1.0,"cholinergic receptor, nicotinic, alpha 3 (neuronal) [Source:HGNC Symbol;Acc:1957]",28.0,1.0,1.0,1.0
189,189,CHRNA3,0.0012340734995183,BipolarDisorder,ENSG00000080644,Tier 1,CHRNA3,15,78885394.0,78913637.0,-1.0,"cholinergic receptor, nicotinic, alpha 3 (neuronal) [Source:HGNC Symbol;Acc:1957]",28.0,1.0,1.0,1.0
189,189,CHRNA3,0.0012340734995183,BrainAneurysm,ENSG00000080644,Tier 1,CHRNA3,15,78885394.0,78913637.0,-1.0,"cholinergic receptor, nicotinic, alpha 3 (neuronal) [Source:HGNC Symbol;Acc:1957]",28.0,1.0,1.0,1.0
189,189,CHRNA3,0.0012340734995183,OCD,ENSG00000080644,Tier 1,CHRNA3,15,78885394.0,78913637.0,-1.0,"cholinergic receptor, nicotinic, alpha 3 (neuronal) [Source:HGNC Symbol;Acc:1957]",28.0,1.0,1.0,1.0
189,189,CHRNA3,0.0012340734995183,Schizophrenia,ENSG00000080644,Tier 1,CHRNA3,15,78885394.0,78913637.0,-1.0,"cholinergic receptor, nicotinic, alpha 3 (neuronal) [Source:HGNC Symbol;Acc:1957]",28.0,1.0,1.0,1.0
189,189,CHRNA3,0.0012340734995183,TouretteSyndrome,ENSG00000080644,Tier 1,CHRNA3,15,78885394.0,78913637.0,-1.0,"cholinergic receptor, nicotinic, alpha 3 (neuronal) [Source:HGNC Symbol;Acc:1957]",28.0,1.0,1.0,1.0
189,189,CHRNA3,0.0012340734995183,UnipolarDepression,ENSG00000080644,Tier 1,CHRNA3,15,78885394.0,78913637.0,-1.0,"cholinergic receptor, nicotinic, alpha 3 (neuronal) [Source:HGNC Symbol;Acc:1957]",28.0,1.0,1.0,1.0
190,190,CHRNA2,0.0012340734995183,AD,ENSG00000120903,Tier 1,CHRNA2,8,27317279.0,27337400.0,-1.0,"cholinergic receptor, nicotinic, alpha 2 (neuronal) [Source:HGNC Symbol;Acc:1956]",0.0,1.0,1.0,1.0
190,190,CHRNA2,0.0012340734995183,PartialEpilepsy,ENSG00000120903,Tier 1,CHRNA2,8,27317279.0,27337400.0,-1.0,"cholinergic receptor, nicotinic, alpha 2 (neuronal) [Source:HGNC Symbol;Acc:1956]",0.0,1.0,1.0,1.0
190,190,CHRNA2,0.0012340734995183,Schizophrenia,ENSG00000120903,Tier 1,CHRNA2,8,27317279.0,27337400.0,-1.0,"cholinergic receptor, nicotinic, alpha 2 (neuronal) [Source:HGNC Symbol;Acc:1956]",0.0,1.0,1.0,1.0
196,196,LAMB3,0.0010966404366271,ALS,ENSG00000196878,Tier 1,LAMB3,1,209788215.0,209825811.0,-1.0,"laminin, beta 3 [Source:HGNC Symbol;Acc:6490]",0.0,1.0,1.0,1.0
212,212,NLGN1,0.0010574506232275,UnipolarDepression,ENSG00000169760,Tier 3B,NLGN1,3,173114074.0,174004434.0,1.0,neuroligin 1 [Source:HGNC Symbol;Acc:14291],0.0,1.0,1.0,1.0
217,217,GRM5,0.0010520659154304,BipolarDisorder,ENSG00000168959,Tier 1,GRM5,11,88237744.0,88799113.0,-1.0,"glutamate receptor, metabotropic 5 [Source:HGNC Symbol;Acc:4597]",10.0,1.0,1.0,1.0
217,217,GRM5,0.0010520659154304,MajorDepressiveDisorder,ENSG00000168959,Tier 1,GRM5,11,88237744.0,88799113.0,-1.0,"glutamate receptor, metabotropic 5 [Source:HGNC Symbol;Acc:4597]",10.0,1.0,1.0,1.0
217,217,GRM5,0.0010520659154304,NeuroticDisorder,ENSG00000168959,Tier 1,GRM5,11,88237744.0,88799113.0,-1.0,"glutamate receptor, metabotropic 5 [Source:HGNC Symbol;Acc:4597]",10.0,1.0,1.0,1.0
217,217,GRM5,0.0010520659154304,UnipolarDepression,ENSG00000168959,Tier 1,GRM5,11,88237744.0,88799113.0,-1.0,"glutamate receptor, metabotropic 5 [Source:HGNC Symbol;Acc:4597]",10.0,1.0,1.0,1.0
221,221,RTN4R,0.0010261070051812,Schizophrenia,ENSG00000040608,Tier 3A,RTN4R,22,20228938.0,20270769.0,-1.0,reticulon 4 receptor [Source:HGNC Symbol;Acc:18601],0.0,1.0,1.0,1.0
223,223,PTPRD,0.0010261070051812,Schizophrenia,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
249,249,CRHR1,0.0009630769074066,PD,ENSG00000120088,Tier 1,CRHR1,17,43699267.0,43913194.0,1.0,corticotropin releasing hormone receptor 1 [Source:HGNC Symbol;Acc:2357],18.0,1.0,1.0,1.0
249,249,CRHR1,0.0009630769074066,Schizophrenia,ENSG00000120088,Tier 1,CRHR1,17,43699267.0,43913194.0,1.0,corticotropin releasing hormone receptor 1 [Source:HGNC Symbol;Acc:2357],18.0,1.0,1.0,1.0
249,249,CRHR1,0.0009630769074066,UnipolarDepression,ENSG00000120088,Tier 1,CRHR1,17,43699267.0,43913194.0,1.0,corticotropin releasing hormone receptor 1 [Source:HGNC Symbol;Acc:2357],18.0,1.0,1.0,1.0
257,257,GPR20,0.0009630769074066,AnorexiaNervosa,ENSG00000204882,Tier 3B,GPR20,8,142366600.0,142377367.0,-1.0,G protein-coupled receptor 20 [Source:HGNC Symbol;Acc:4475],0.0,1.0,1.0,1.0
257,257,GPR20,0.0009630769074066,BipolarDisorder,ENSG00000204882,Tier 3B,GPR20,8,142366600.0,142377367.0,-1.0,G protein-coupled receptor 20 [Source:HGNC Symbol;Acc:4475],0.0,1.0,1.0,1.0
257,257,GPR20,0.0009630769074066,OCD,ENSG00000204882,Tier 3B,GPR20,8,142366600.0,142377367.0,-1.0,G protein-coupled receptor 20 [Source:HGNC Symbol;Acc:4475],0.0,1.0,1.0,1.0
257,257,GPR20,0.0009630769074066,Schizophrenia,ENSG00000204882,Tier 3B,GPR20,8,142366600.0,142377367.0,-1.0,G protein-coupled receptor 20 [Source:HGNC Symbol;Acc:4475],0.0,1.0,1.0,1.0
257,257,GPR20,0.0009630769074066,TouretteSyndrome,ENSG00000204882,Tier 3B,GPR20,8,142366600.0,142377367.0,-1.0,G protein-coupled receptor 20 [Source:HGNC Symbol;Acc:4475],0.0,1.0,1.0,1.0
257,257,GPR20,0.0009630769074066,UnipolarDepression,ENSG00000204882,Tier 3B,GPR20,8,142366600.0,142377367.0,-1.0,G protein-coupled receptor 20 [Source:HGNC Symbol;Acc:4475],0.0,1.0,1.0,1.0
261,261,ADCY2,0.0009552597644415,BipolarDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
261,261,ADCY2,0.0009552597644415,UnipolarDepression,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
263,263,PTPRG,0.0009391386896255,AD,ENSG00000144724,Tier 3A,PTPRG,3,61547243.0,62283288.0,1.0,"protein tyrosine phosphatase, receptor type, G [Source:HGNC Symbol;Acc:9671]",0.0,1.0,1.0,1.0
267,267,CD80,0.0009354816615637,MS,ENSG00000121594,Tier 1,CD80,3,119243140.0,119278449.0,-1.0,CD80 molecule [Source:HGNC Symbol;Acc:1700],6.0,1.0,1.0,1.0
281,281,GPR151,0.000907645126407,EssentialTremor,ENSG00000173250,Tier 3B,GPR151,5,145892666.0,145895753.0,-1.0,G protein-coupled receptor 151 [Source:HGNC Symbol;Acc:23624],0.0,1.0,1.0,1.0
283,283,LTBR,0.0008920626447231,MS,ENSG00000111321,Tier 1,LTBR,12,6484211.0,6500733.0,1.0,"lymphotoxin beta receptor (TNFR superfamily, member 3) [Source:HGNC Symbol;Acc:6718]",1.0,1.0,1.0,1.0
287,287,UNC5C,0.0008879281649972,AD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
299,299,LRIG1,0.0008718696175088,AD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
307,307,HBEGF,0.0008718696175088,AD,ENSG00000113070,Tier 1,HBEGF,5,139712428.0,139726216.0,-1.0,heparin-binding EGF-like growth factor [Source:HGNC Symbol;Acc:3059],0.0,1.0,1.0,1.0
310,310,SLC10A2,0.000866427938772,AD,ENSG00000125255,Tier 1,SLC10A2,13,103696350.0,103719196.0,-1.0,"solute carrier family 10 (sodium/bile acid cotransporter), member 2 [Source:HGNC Symbol;Acc:10906]",0.0,1.0,1.0,1.0
315,315,MMP3,0.000866427938772,AD,ENSG00000149968,Tier 1,MMP3,11,102706532.0,102714534.0,-1.0,"matrix metallopeptidase 3 (stromelysin 1, progelatinase) [Source:HGNC Symbol;Acc:7173]",7.0,1.0,1.0,1.0
321,321,IDE,0.000866427938772,ALS,ENSG00000119912,Tier 2,IDE,10,94211441.0,94333833.0,-1.0,insulin-degrading enzyme [Source:HGNC Symbol;Acc:5381],10.0,1.0,1.0,1.0
323,323,JAG1,0.0008550181906362,MigraineDisorder,ENSG00000101384,Tier 3A,JAG1,20,10618332.0,10654694.0,-1.0,jagged 1 [Source:HGNC Symbol;Acc:6188],1.0,1.0,1.0,1.0
331,331,BMP8A,0.0008542216878103,MigraineDisorder,ENSG00000183682,Tier 3A,BMP8A,1,39957318.0,39991607.0,1.0,bone morphogenetic protein 8a [Source:HGNC Symbol;Acc:21650],4.0,1.0,1.0,1.0
334,334,AKT3,0.000850139674199,AnorexiaNervosa,ENSG00000117020,Tier 1,AKT3,1,243651535.0,244014381.0,-1.0,v-akt murine thymoma viral oncogene homolog 3 [Source:HGNC Symbol;Acc:393],1.0,1.0,1.0,1.0
334,334,AKT3,0.000850139674199,Schizophrenia,ENSG00000117020,Tier 1,AKT3,1,243651535.0,244014381.0,-1.0,v-akt murine thymoma viral oncogene homolog 3 [Source:HGNC Symbol;Acc:393],1.0,1.0,1.0,1.0
335,335,CILK1,0.0008498572962282,PartialEpilepsy,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
336,336,CHRM2,0.0008498572962282,MajorDepressiveDisorder,ENSG00000181072,Tier 1,CHRM2,7,136553416.0,136705002.0,1.0,"cholinergic receptor, muscarinic 2 [Source:HGNC Symbol;Acc:1951]",1.0,1.0,1.0,1.0
336,336,CHRM2,0.0008498572962282,UnipolarDepression,ENSG00000181072,Tier 1,CHRM2,7,136553416.0,136705002.0,1.0,"cholinergic receptor, muscarinic 2 [Source:HGNC Symbol;Acc:1951]",1.0,1.0,1.0,1.0
341,341,HP,0.0008481002521305,AnorexiaNervosa,ENSG00000257017,Tier 3A,HP,16,72088491.0,72094954.0,1.0,haptoglobin [Source:HGNC Symbol;Acc:5141],7.0,1.0,1.0,1.0
341,341,HP,0.0008481002521305,BipolarDisorder,ENSG00000257017,Tier 3A,HP,16,72088491.0,72094954.0,1.0,haptoglobin [Source:HGNC Symbol;Acc:5141],7.0,1.0,1.0,1.0
341,341,HP,0.0008481002521305,OCD,ENSG00000257017,Tier 3A,HP,16,72088491.0,72094954.0,1.0,haptoglobin [Source:HGNC Symbol;Acc:5141],7.0,1.0,1.0,1.0
341,341,HP,0.0008481002521305,Schizophrenia,ENSG00000257017,Tier 3A,HP,16,72088491.0,72094954.0,1.0,haptoglobin [Source:HGNC Symbol;Acc:5141],7.0,1.0,1.0,1.0
341,341,HP,0.0008481002521305,TouretteSyndrome,ENSG00000257017,Tier 3A,HP,16,72088491.0,72094954.0,1.0,haptoglobin [Source:HGNC Symbol;Acc:5141],7.0,1.0,1.0,1.0
341,341,HP,0.0008481002521305,UnipolarDepression,ENSG00000257017,Tier 3A,HP,16,72088491.0,72094954.0,1.0,haptoglobin [Source:HGNC Symbol;Acc:5141],7.0,1.0,1.0,1.0
345,345,APOB,0.0008481002521305,AD,ENSG00000084674,Tier 1,APOB,2,21224301.0,21266945.0,-1.0,apolipoprotein B [Source:HGNC Symbol;Acc:603],36.0,1.0,1.0,1.0
345,345,APOB,0.0008481002521305,BipolarDisorder,ENSG00000084674,Tier 1,APOB,2,21224301.0,21266945.0,-1.0,apolipoprotein B [Source:HGNC Symbol;Acc:603],36.0,1.0,1.0,1.0
350,350,PLXNC1,0.000843609805886,MS,ENSG00000136040,Tier 3B,PLXNC1,12,94542499.0,94701451.0,1.0,plexin C1 [Source:HGNC Symbol;Acc:9106],0.0,1.0,1.0,1.0
351,351,PLXNA4,0.000843609805886,BipolarDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
351,351,PLXNA4,0.000843609805886,Schizophrenia,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
356,356,STAT6,0.0008365693300438,MigraineDisorder,ENSG00000166888,Tier 2,STAT6,12,57489191.0,57525922.0,-1.0,"signal transducer and activator of transcription 6, interleukin-4 induced [Source:HGNC Symbol;Acc:11368]",8.0,1.0,1.0,1.0
356,356,STAT6,0.0008365693300438,MigraineWithAura,ENSG00000166888,Tier 2,STAT6,12,57489191.0,57525922.0,-1.0,"signal transducer and activator of transcription 6, interleukin-4 induced [Source:HGNC Symbol;Acc:11368]",8.0,1.0,1.0,1.0
356,356,STAT6,0.0008365693300438,Schizophrenia,ENSG00000166888,Tier 2,STAT6,12,57489191.0,57525922.0,-1.0,"signal transducer and activator of transcription 6, interleukin-4 induced [Source:HGNC Symbol;Acc:11368]",8.0,1.0,1.0,1.0
365,365,TNK2,0.0008274462436528,PD,ENSG00000061938,Tier 1,TNK2,3,195590235.0,195638816.0,-1.0,"tyrosine kinase, non-receptor, 2 [Source:HGNC Symbol;Acc:19297]",0.0,1.0,1.0,1.0
381,381,PTPRJ,0.0008274462436528,AD,ENSG00000149177,Tier 3A,PTPRJ,11,48002113.0,48189670.0,1.0,"protein tyrosine phosphatase, receptor type, J [Source:HGNC Symbol;Acc:9673]",7.0,1.0,1.0,1.0
387,387,TXK,0.0008274462436528,MS,ENSG00000074966,Tier 1,TXK,4,48068410.0,48136273.0,-1.0,TXK tyrosine kinase [Source:HGNC Symbol;Acc:12434],0.0,1.0,1.0,1.0
389,389,TUBA4A,0.0008274462436528,ALS,ENSG00000127824,Tier 3B,TUBA4A,2,220114433.0,220142892.0,-1.0,"tubulin, alpha 4a [Source:HGNC Symbol;Acc:12407]",0.0,1.0,1.0,1.0
399,399,AATK,0.0008274462436528,NeuroticDisorder,ENSG00000181409,Tier 3A,AATK,17,79091095.0,79139877.0,-1.0,apoptosis-associated tyrosine kinase [Source:HGNC Symbol;Acc:21],0.0,1.0,1.0,1.0
399,399,AATK,0.0008274462436528,UnipolarDepression,ENSG00000181409,Tier 3A,AATK,17,79091095.0,79139877.0,-1.0,apoptosis-associated tyrosine kinase [Source:HGNC Symbol;Acc:21],0.0,1.0,1.0,1.0
405,405,CSF2RB,0.0008274462436528,MS,ENSG00000100368,Tier 3A,CSF2RB,22,37309670.0,37336491.0,1.0,"colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) [Source:HGNC Symbol;Acc:2436]",0.0,1.0,1.0,1.0
407,407,CNTN1,0.0008274462436528,PD,ENSG00000018236,Tier 3A,CNTN1,12,41086244.0,41466220.0,1.0,contactin 1 [Source:HGNC Symbol;Acc:2171],1.0,1.0,1.0,1.0
414,414,CD5,0.0008274462436528,MS,ENSG00000110448,Tier 1,CD5,11,60869867.0,60895324.0,1.0,CD5 molecule [Source:HGNC Symbol;Acc:1685],0.0,1.0,1.0,1.0
424,424,FCGR2A,0.0008274462436528,PD,ENSG00000143226,Tier 3A,FCGR2A,1,161475220.0,161493803.0,1.0,"Fc fragment of IgG, low affinity IIa, receptor (CD32) [Source:HGNC Symbol;Acc:3616]",6.0,1.0,1.0,1.0
440,440,ERBB2,0.0008274462436528,BipolarDisorder,ENSG00000141736,Tier 1,ERBB2,17,37844167.0,37886679.0,1.0,v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 [Source:HGNC Symbol;Acc:3430],3.0,1.0,1.0,1.0
445,445,NOX4,0.0008274462436528,AnorexiaNervosa,ENSG00000086991,Tier 2,NOX4,11,89057524.0,89322779.0,-1.0,NADPH oxidase 4 [Source:HGNC Symbol;Acc:7891],11.0,1.0,1.0,1.0
445,445,NOX4,0.0008274462436528,BipolarDisorder,ENSG00000086991,Tier 2,NOX4,11,89057524.0,89322779.0,-1.0,NADPH oxidase 4 [Source:HGNC Symbol;Acc:7891],11.0,1.0,1.0,1.0
445,445,NOX4,0.0008274462436528,OCD,ENSG00000086991,Tier 2,NOX4,11,89057524.0,89322779.0,-1.0,NADPH oxidase 4 [Source:HGNC Symbol;Acc:7891],11.0,1.0,1.0,1.0
445,445,NOX4,0.0008274462436528,Schizophrenia,ENSG00000086991,Tier 2,NOX4,11,89057524.0,89322779.0,-1.0,NADPH oxidase 4 [Source:HGNC Symbol;Acc:7891],11.0,1.0,1.0,1.0
445,445,NOX4,0.0008274462436528,TouretteSyndrome,ENSG00000086991,Tier 2,NOX4,11,89057524.0,89322779.0,-1.0,NADPH oxidase 4 [Source:HGNC Symbol;Acc:7891],11.0,1.0,1.0,1.0
445,445,NOX4,0.0008274462436528,UnipolarDepression,ENSG00000086991,Tier 2,NOX4,11,89057524.0,89322779.0,-1.0,NADPH oxidase 4 [Source:HGNC Symbol;Acc:7891],11.0,1.0,1.0,1.0
458,458,PDGFRB,0.0008274462436528,PD,ENSG00000113721,Tier 1,PDGFRB,5,149493400.0,149535435.0,-1.0,"platelet-derived growth factor receptor, beta polypeptide [Source:HGNC Symbol;Acc:8804]",0.0,1.0,1.0,1.0
462,462,MST1R,0.0008274462436528,Schizophrenia,ENSG00000164078,Tier 1,MST1R,3,49924435.0,49941299.0,-1.0,macrophage stimulating 1 receptor (c-met-related tyrosine kinase) [Source:HGNC Symbol;Acc:7381],3.0,1.0,1.0,1.0
463,463,FLOT1,0.0008274462436528,UnipolarDepression,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
469,469,LPP,0.0008274462436528,MS,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
469,469,LPP,0.0008274462436528,Schizophrenia,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
473,473,CD226,0.0008274462436528,MS,ENSG00000150637,Tier 3A,CD226,18,67498394.0,67629039.0,-1.0,CD226 molecule [Source:HGNC Symbol;Acc:16961],7.0,1.0,1.0,1.0
474,474,CD19,0.0008274462436528,PD,ENSG00000177455,Tier 1,CD19,16,28943260.0,28950667.0,1.0,CD19 molecule [Source:HGNC Symbol;Acc:1633],8.0,1.0,1.0,1.0
475,475,LRP1,0.0008211415545289,MigraineDisorder,ENSG00000123384,Tier 3A,LRP1,12,57522276.0,57607134.0,1.0,low density lipoprotein receptor-related protein 1 [Source:HGNC Symbol;Acc:6692],7.0,1.0,1.0,1.0
475,475,LRP1,0.0008211415545289,MigraineWithAura,ENSG00000123384,Tier 3A,LRP1,12,57522276.0,57607134.0,1.0,low density lipoprotein receptor-related protein 1 [Source:HGNC Symbol;Acc:6692],7.0,1.0,1.0,1.0
475,475,LRP1,0.0008211415545289,Schizophrenia,ENSG00000123384,Tier 3A,LRP1,12,57522276.0,57607134.0,1.0,low density lipoprotein receptor-related protein 1 [Source:HGNC Symbol;Acc:6692],7.0,1.0,1.0,1.0
480,480,SCARB1,0.0008211415545289,AD,ENSG00000073060,Tier 2,SCARB1,12,125261402.0,125367214.0,-1.0,"scavenger receptor class B, member 1 [Source:HGNC Symbol;Acc:1664]",6.0,1.0,1.0,1.0
482,482,VRK2,0.000820175845041,AnorexiaNervosa,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,1.0,1.0
482,482,VRK2,0.000820175845041,BipolarDisorder,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,1.0,1.0
482,482,VRK2,0.000820175845041,MajorDepressiveDisorder,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,1.0,1.0
482,482,VRK2,0.000820175845041,OCD,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,1.0,1.0
482,482,VRK2,0.000820175845041,PartialEpilepsy,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,1.0,1.0
482,482,VRK2,0.000820175845041,Schizophrenia,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,1.0,1.0
482,482,VRK2,0.000820175845041,TouretteSyndrome,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,1.0,1.0
482,482,VRK2,0.000820175845041,UnipolarDepression,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,1.0,1.0
498,498,ITGA2B,0.0007915528548235,AD,ENSG00000005961,Tier 1,ITGA2B,17,42449548.0,42466873.0,-1.0,"integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) [Source:HGNC Symbol;Acc:6138]",1.0,1.0,1.0,1.0
498,498,ITGA2B,0.0007915528548235,PD,ENSG00000005961,Tier 1,ITGA2B,17,42449548.0,42466873.0,-1.0,"integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) [Source:HGNC Symbol;Acc:6138]",1.0,1.0,1.0,1.0
501,501,HDAC4,0.0007915528548235,BrainAneurysm,ENSG00000068024,Tier 1,HDAC4,2,239969864.0,240323348.0,-1.0,histone deacetylase 4 [Source:HGNC Symbol;Acc:14063],0.0,1.0,1.0,1.0
504,504,ITGA9,0.0007915528548235,ALS,ENSG00000144668,Tier 3A,ITGA9,3,37493606.0,37865005.0,1.0,"integrin, alpha 9 [Source:HGNC Symbol;Acc:6145]",3.0,1.0,1.0,1.0
506,506,SRPK2,0.0007906973499228,AnorexiaNervosa,ENSG00000135250,Tier 1,SRPK2,7,104751151.0,105039755.0,-1.0,SRSF protein kinase 2 [Source:HGNC Symbol;Acc:11306],1.0,1.0,1.0,1.0
506,506,SRPK2,0.0007906973499228,BipolarDisorder,ENSG00000135250,Tier 1,SRPK2,7,104751151.0,105039755.0,-1.0,SRSF protein kinase 2 [Source:HGNC Symbol;Acc:11306],1.0,1.0,1.0,1.0
506,506,SRPK2,0.0007906973499228,OCD,ENSG00000135250,Tier 1,SRPK2,7,104751151.0,105039755.0,-1.0,SRSF protein kinase 2 [Source:HGNC Symbol;Acc:11306],1.0,1.0,1.0,1.0
506,506,SRPK2,0.0007906973499228,Schizophrenia,ENSG00000135250,Tier 1,SRPK2,7,104751151.0,105039755.0,-1.0,SRSF protein kinase 2 [Source:HGNC Symbol;Acc:11306],1.0,1.0,1.0,1.0
506,506,SRPK2,0.0007906973499228,TouretteSyndrome,ENSG00000135250,Tier 1,SRPK2,7,104751151.0,105039755.0,-1.0,SRSF protein kinase 2 [Source:HGNC Symbol;Acc:11306],1.0,1.0,1.0,1.0
506,506,SRPK2,0.0007906973499228,UnipolarDepression,ENSG00000135250,Tier 1,SRPK2,7,104751151.0,105039755.0,-1.0,SRSF protein kinase 2 [Source:HGNC Symbol;Acc:11306],1.0,1.0,1.0,1.0
507,507,CHI3L1,0.0007815622429015,Schizophrenia,ENSG00000133048,Tier 3A,CHI3L1,1,203148059.0,203155877.0,-1.0,chitinase 3-like 1 (cartilage glycoprotein-39) [Source:HGNC Symbol;Acc:1932],0.0,1.0,1.0,1.0
508,508,PSEN1,0.0007815622429015,AD,ENSG00000080815,Tier 1,PSEN1,14,73603126.0,73690399.0,1.0,presenilin 1 [Source:HGNC Symbol;Acc:9508],0.0,1.0,1.0,1.0
508,508,PSEN1,0.0007815622429015,FrontotemporalDementia,ENSG00000080815,Tier 1,PSEN1,14,73603126.0,73690399.0,1.0,presenilin 1 [Source:HGNC Symbol;Acc:9508],0.0,1.0,1.0,1.0
510,510,IAPP,0.0007810772690138,ProgressiveSupranuclearPalsy,ENSG00000121351,Tier 1,IAPP,12,21507893.0,21532912.0,1.0,islet amyloid polypeptide [Source:HGNC Symbol;Acc:5329],0.0,1.0,1.0,1.0
511,511,SPON1,0.0007810772690138,AD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
514,514,TNFSF18,0.000774818164754,NarcolepsyCataplexy,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
514,514,TNFSF18,0.000774818164754,Narcolepsy,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
524,524,NGF,0.000774818164754,MigraineDisorder,ENSG00000134259,Tier 1,NGF,1,115828539.0,115880857.0,-1.0,nerve growth factor (beta polypeptide) [Source:HGNC Symbol;Acc:7808],0.0,1.0,1.0,1.0
527,527,HGF,0.000774818164754,AD,ENSG00000019991,Tier 1,HGF,7,81328322.0,81399754.0,-1.0,hepatocyte growth factor (hepapoietin A; scatter factor) [Source:HGNC Symbol;Acc:4893],0.0,1.0,1.0,1.0
538,538,HCRT,0.000774818164754,NarcolepsyCataplexy,ENSG00000161610,Tier 3B,HCRT,17,40336078.0,40337470.0,-1.0,hypocretin (orexin) neuropeptide precursor [Source:HGNC Symbol;Acc:4847],0.0,1.0,1.0,1.0
538,538,HCRT,0.000774818164754,Narcolepsy,ENSG00000161610,Tier 3B,HCRT,17,40336078.0,40337470.0,-1.0,hypocretin (orexin) neuropeptide precursor [Source:HGNC Symbol;Acc:4847],0.0,1.0,1.0,1.0
545,545,PRKAG1,0.0007676855749943,BipolarDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
551,551,IL7,0.0007553648942316,MS,ENSG00000104432,Tier 3A,IL7,8,79587978.0,79717758.0,-1.0,interleukin 7 [Source:HGNC Symbol;Acc:6023],0.0,1.0,1.0,1.0
558,558,LTBP3,0.0006908691485981,UnipolarDepression,ENSG00000168056,Tier 3A,LTBP3,11,65306276.0,65326401.0,-1.0,latent transforming growth factor beta binding protein 3 [Source:HGNC Symbol;Acc:6716],3.0,1.0,1.0,1.0
